Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07414576 · ClinicalTrials.gov registry record · NA
AI-driven Total Parenteral Nutrition Platform
A NA study of Intestinal Failure, sponsored by Takeoff41.
- Recruiting
- Registry status
- NA
- Development phase
- 260
- Enrollment target
- 1
- Study location
NCT07414576: Recruiting NA study of Intestinal Failure, sponsored by Takeoff41.
NCT07414576 is a NA study of Intestinal Failure that is actively recruiting participants, run by Takeoff41. The registered enrollment target is 260 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07414576, a NA study of Intestinal Failure, is actively recruiting participants, sponsored by Takeoff41.
- RECRUITING
- Registry status
- NA
- Development phase
- 260 participants
- Enrollment target
- 1
- Study location
Study Summary
This study tests whether an artificial intelligence (AI) tool can help doctors order total parenteral nutrition (TPN) for babies in the neonatal intensive care unit (NICU). Premature babies often cannot eat by mouth and need nutrition delivered through an IV. Ordering TPN is complex, time-consuming, and mistakes can happen. This study will test an AI tool that suggests TPN formulas to doctors based on each baby's lab values and health information. Doctors can accept, change, or reject the suggestions at any time. The main goal is to measure how often doctors accept the AI suggestions. The study will also track time to complete TPN orders, weight changes, days on TPN, whether lab values stay in normal ranges, provider satisfaction, and baby health outcomes including complications such as lung disease, brain bleeding, infections, and other conditions common in premature babies. Babies admitted to the NICU who need TPN may participate if their doctors agree to use the tool. Each baby will be in the study while they need TPN, typically about 14 days. The AI tool only makes suggestions and does not replace doctor decision-making. All other care remains the same as standard practice.
Primary Outcome
Percentage of AI-generated recommendations that are accepted or modified by providers for each ingredient of TPN. Measured by retrospective comparison between AI suggestion and actual TPN order submitted.
Conditions Studied
Interventions
- DEVICE AI-driven total parenteral nutrition (TPN)
Study Locations (1)
California
- Stanford University - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2026-01-21 |
| Est. Completion | 2027-02-21 |
| Phase | NA |
What NCT07414576 shows while recruiting
NCT07414576 is an interventional study that assigns participants to a tested intervention. The registered 260 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower).
The record links to 1 condition, with Intestinal Failure appearing as the primary indexed condition, and to 1 intervention - of which AI-driven total parenteral nutrition (TPN) is the first listed.
NCT07414576 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07414576 about?
NCT07414576 is a clinical study titled "AI-driven Total Parenteral Nutrition Platform". This study tests whether an artificial intelligence (AI) tool can help doctors order total parenteral nutrition (TPN) for babies in the neonatal intensive care unit (NICU). Premature babies often cannot eat by mouth and need nutrition delivered through an IV. Ordering TPN is complex, time-consuming,...
What is the current status of trial NCT07414576?
This trial is currently recruiting. It is a NA study. The enrollment target is 260 participants. The study started on 2026-01-21. Estimated completion is 2027-02-21.
What conditions does trial NCT07414576 study?
This clinical trial studies the following conditions: Intestinal Failure.
What interventions are being tested in trial NCT07414576?
The interventions under investigation include: AI-driven total parenteral nutrition (TPN) (DEVICE).
Who is sponsoring clinical trial NCT07414576?
This trial is sponsored by Takeoff41, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07414576 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intestinal Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07414576's enrollment target sits among peer trials
260 397th of 2000 higher than 1,602 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02283996 · 260 participants · Phase 4
Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment
- NCT03276793 · 260 participants · NA
Brain Connectivity in Depression
- NCT03407469 · 260 participants
Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization
- NCT03713125 · 260 participants · NA
Executive Function in Early Childhood
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI